Compound ID | 240
Class: RNA synthesis inhibitor
Spectrum of activity: | Gram-positive |
Details of activity: | Compound 363 inhibited the growth of methicillin-resistant S. aureus and exhibited therapeutic effects in both silkworm and mouse infection models with low toxicity. Targets RNA polymerase sigma factor |
Institute where first reported: | Graduate Sch. Of Pharmaceitucl Sci. University of Tokyo, Japan |
Year first mentioned: | 2014 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/46357521 |
Citations: |
|